[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis]. [electronic resource]
Producer: 20011018Description: 462-72 p. digitalISSN:- 0085-4530
- Administration, Oral
- Age Factors
- Aged
- Bone Density
- Breast Neoplasms -- chemically induced
- Clinical Trials as Topic
- Estradiol -- administration & dosage
- Estrogen Antagonists -- administration & dosage
- Estrogen Replacement Therapy -- adverse effects
- Estrogens, Conjugated (USP) -- administration & dosage
- Female
- Fractures, Bone -- prevention & control
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Progestins -- administration & dosage
- Raloxifene Hydrochloride -- administration & dosage
- Risk Factors
- Selective Estrogen Receptor Modulators -- therapeutic use
- Time Factors
- Uterine Neoplasms -- chemically induced
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.